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Summary: A highly sensitive radioimmunoassay for arginine8-vasopressin (argipressin; INN) measurement
was developed using Amberlite XAD 2 resin columns to extract arginine8-vasopressin from acidified human
plasma. Arginine8-vasopressin was determined by a rapid radioimmunoassay method (2 20 ) using a
specific antibody and 125I-labelled antigen. The bound fraction was separated by adsorption of the free fraction
onto bovine serum albumin-coated charcoal; this resulted in low unspecific binding of less than 2%. Recovery
experiments in the physiological range resulted in a mean (± SEM) recovery of 88 ± 3%. The radioimmu-
noassay consistently yielded a detection limit of 0.3 ng/1 (ED90) and a mean 50% binding intercept (ED50) of
3.5 ng/1. Arginine8-vasopressin immunoreactivity was characterized by reverse-phase high performance liquid
chromatography, which confirmed the specificity of the assay. Serial plasma dilution curves paralleled the
standard curve. The intra- and inter-assay variations were 9.4% and 15%, respectively. Arginine8-vasopressin
concentrations in healthy subjects were determined in normal hydration status (2.2 ± 0.3 ng/1; n = 11), as
well as during suppression by water immersion (1.5 ± 0.2 ng/1; n = 11) or by water loading (1.6 ± 0.2 ng/1;
n = 8). Thus, this assay allows for a sensitive, accurate and rapid quantification of plasma arginine8-
vasopressin concentrations.
Introduction
Alterations of arginine8-vasopressin plasma concen- pressin by radioimmunoassay have been hampered by
trations seem to be involved in the abnormal water the presence of different interfering factors which are
handling that is present in several diseases. Thus, still only partially characterized. Thus, limited speci-
investigations in patients with congestive heart failure ficity is inherent in the methods using direct radioim-
(1 — 3), hyperaldosteronism (4) or syndrome of inap- munoassay for arginine8-vasopressinin plasma (9,10),
propriate antidiuresis (5, 6) demonstrated abnormal necessitating plasma extraction before radioimmu-
arginine8-vasopressin secretion as a determinant of noassay of the neurohypophyseal peptide. Different
impaired water balance. Furthermore, any investiga- extraction procedures have been used, including the
tion of the physiological regulation of water homeo- use of acetone and petroleum ether (11, 12), cold
stasis should comprise determination of arginine8- ethanol (13) or Bentonite (14), but they show poor
vasopressin plasma concentrations (7, 8). Therefore, and variable recoveries (11, 13). Furthermore, several
an accurate determination of arginine8-vasopressin is radioimmunoassays for arginine8-vasopressin involve
important for both physiological and clinical pur- complicated separation techniques, and in order to
poses. Efforts to obtain an exact measurement of the obtain adequate sensitivity they employ incubation
rather low plasma concentrations of arginine8-vaso- periods of up to 7 days (9,15).
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Therefore we have developed a simple, accurate and
rapid method for determining arginine8-vasopressin
following extraction from plasma. The method has a
very low detection limit.
Materials and Methods
Material
Sample preparation and extraction
Blood was collected in disodium ethylenediaminetetraacetate
coated tubes and immediately centrifuged at 2000 g for 10 min
at 4 °C. The plasma was removed, treated with phenylmethyl-
sulphonylfluoride (5 mmol/1) and acidified with acetic acid to
pH 5.5 (2.5 mol/1). For extraction the plasma samples were
adsorbed as 1 ml aliquots to activated Amberlite XAD 2 resin
(Serva, Heidelberg, Germany) chromatography columns (Bio-
Rad Laboratories, Richmond, CA 94804) followed by washing
with trifluoroacetic acid (1 mmol/1). The elution was performed
using a mobile phase consisting of 1 mol/1 acetonitrile (80%)
and 1 mmol/1 trifluoroacetic acid (20%). The lyophilized sam-
ples were reconstituted in 300 μΐ assay buffer I.
Recovery
Recovery experiments were performed by parallel extraction of
1, 2, 4 and 8 pg synthetic arginine8-vasopressin (Bissendorf
Biochemicals GmbH, Hannover, Germany) added to 1 ml ali-
quots of different plasma samples.
Assay buffers
Two assay buffers were used in this radioimmunoassay.
Assay buffer I was prepared with 20 g/1 of bovine serum
albumin in 50 mmol/1 phosphate buffer (pH 7.4) containing
5 mmol/1 phenylmethylsulphonylfluoride, 0.1 mol/1 sodium
chloride, 10 mmol/1 disodium ethylenediaminetetraacetate and
0.1 mol/1 Triton X-100. After incubation for 4 h at 56 °C the
buffer was diluted 10 fold. Neomycin sulphate (2 g/1) and so-
dium azide (1 g/1) were then added and the pH adjusted to 7.4.
For assay buffer II dissolved gelatine (1 g/1) was added to 20
mmol/1 phosphate buffer containing 0.15 mol/1 sodium chloride,
0.1 g/1 bovine serum albumin and 0.1 g/1 thimerosal. Thereafter
the pH was adjusted with sodium hydroxide (10 mol/1) to 7.4.
Standard curve
Known amounts of synthetic arginine8-vasopressin were serially
diluted ranging from 80 to 0.08 ng/1 in assay buffer I.
Methods
Assay protocol
Polyclonal antibody (Nol 728-6), generated against synthetic
arginine8-vasopressin bovine thyroglobulin conjugates in rab-
bits (16), was diluted to bind about a third of the total radio-
labelled antigen added in the absence of unlabelled antigen.
Antiserum (100 μΐ, end dilution 1 : 50000) was added to stand-
ards and extracted antigens. Incubation was carried out in
polypropylene tubes for 20 h at 4°C. Then, 1.6 pg/tube 125I-
labelled arginine8-vasopressin (Amersham Braunschweig, Ger-
many, 74 TBq/mmol (2000 Ci/mmol); 100 μΐ) was added, fol-
lowed by incubation at 4 °C for a further 20 h.
In order to determine cross-reactivities of the antibody with
other peptides, standard curves of the radioimmunoassay were
performed with ocytocin, atrial natriuretic peptide, angiotensin
II and Iysine8-vasopressin, respectively, instead of unlabelled
arginine8-vasopressin.
Separation
Separation was performed by adding 500 μΐ of bovine serum
albumin-coated charcoal (29%/71%, by weight) dissolved in
assay buffer II. After 10 min, standards and samples were
centrifuged at 4 °C for 10 min at 2000 £ and the supernatant
was counted (LKB, Turku, Finland, 80% efficiency) in tripli-
cate.
Non-specific binding was determined by performing the ra-
dioimmunoassay without antibody (n = 9).
Reverse-phase-H P LC
Arginine8-vasopressin immunoreactivity was characterized by
reverse-phase high performance liquid chromatography
(n = 6). For calibration a standard of 200 pg synthetic
arginine8-vasopressin was dissolved in 250 μΐ acetonitrile and
submitted to reverse-phase high performance liquid chroma-
tography (Cg-ultrapore TM column [5 μιη], Beckman San Ra-
mon, U.S.A.). Standard and extracted samples were eluted
with a linear gradient from 15% —45% acetonitrile in 1 mmol/1
trifluoroacetic acid in 35 min (flow rate 0.5 ml/min, fraction
size 0.5 ml/tube). Subsequently, the hormone contents of the
fractions were measured by radioimmunoassay.
Water immersion
Water immersion was performed as described in detail elsewhere
(17 — 19). Briefly, following l h in the sitting position at room
temperature (28 °C) beside the water thank, 11 healthy, nor-
mally hydrated subjects were immersed to the level of the neck
into thermoneutral water (34.5 °C) for l h followed by l h
outside the tank. Blood samples were taken immediately before,
after l h immersion and l h after exiting the tank.
Water loading
After an overnight fast (16 h) blood samples (basal value) were
taken from 8 healthy volunteers. Thereafter the subjects were
orally water loaded with 20 ml/kg body weight within 30 min
and blood samples were taken 1 h later.
All data are given as mean ± standard error of the mean.
Significance of differences was tested by the Student t-test.
Results
Recovery experiments (n = 11) with physiological
concentrations of synthetic arginine8-vasopressin
added to different plasma samples prior to extraction
showed a linear relationship between added and de-
termined arginine8-vasopressin concentration with a
mean recovery of 88 ± 3%. Figure 1 illustrates a
typical standard curve for the radioimmunoassay of
arginine8-vasopressin with the 50% binding intercept
(ED50) at 3.5 ng/1 and a lower detection limit (ED90)
of 0.3 ng/1 (n = 8). Serial dilutions of 0.5, 1, 2 and
4 ml plasma paralleled the standard curve. The intra-
assay coefficient of variation (n = 8) averaged 9.4%,
the inter-assay coefficient of variation (n = 8) was
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Fig. 2. Coelution of arginine8-vasopressin immunoreactivity of
an extracted plasma sample with synthetic arginine8-
vasopressin by reverse-phase high performance liquid
chromatography analysis, confirming the specificity of
the assay.
15%. No cross-reactivity of the anti-arginine8-vaso-
pressin antibody to ocytocin, atrial natriuretic peptide
and angiotensin II could be observed. The cross-
reactivity to Iysine8-vasopressin was 3%. The non-
specific binding was less than 2%.
Reverse-phase high performance liquid chromato-
graphy analysis revealed coelution of immunoreactive
arginine8-vasopressin with synthetic arginine8-vaso-
pressin as a single peak (fig. 2).
Central volume stimulation by l h head-out water
immersion in 11 healthy subjects produced a signifi-
cant drop (2.2 ± 0.3 vs. 1.5 ± 0.2 ng/l, p < 0.05) of
arginine8-vasopressin plasma concentrations. In the
recovery period, arginine8-vasopressin returned to
baseline concentrations (1.5 ± 0.2 vs. 2.0 ± 0.3 ng/l,
p < 0.05). Oral water loading of 8 healthy subjects
significantly decreased arginine8-vasopressin plasma
concentrations (2.0 ± 0.2 vs. 1.6 ± 0.2 ng/l,
p < 0.05) as well as plasma osmolality (282 ± 5.5 vs.
274 ± 4.4 mosmol/kg, p < 0.05). Arginine8-vaso-
pressin plasma concentrations were significantly cor-
related with plasma osmolality (r = 0.83, p < 0.01).
Discussion
Due to the very low plasma concentration of
arginine8-vasopressin and the presence of inade-
quately characterized interfering factors, the devel-
opment of a sensitive and specific radioimmunoassay
for arginine8-vasopressin has proved to be more dif-
ficult than for many other peptides (9).
In contrast to a variety of less specific antisera raised
for vasopressin determination (20 — 23), we used a
highly specific one (16). Due to the specificity of this
antibody (confirmed by cross-reactivity experiments
and high performance liquid chromatography analy-
sis), the extraction procedure was simpler than those
reported previously for other methods. The usefulness
of this Amberlite XAD 2 resin extraction procedure
was confirmed by the linear relationship between
added and measured arginine8-vasopressin concentra-
tion in the recovery experiments, as well as by a
reliable mean recovery rate of 88%.
Tab. 1. Arginine8-vasopressin assays described by different authors
Author
Eichet, D. G. (24)
Bie, P. (25)
Bodola, F. (26)
D rr, J. A. (27)
Fyhrquist, F. (10)
Gerbes, A. L. (this paper)
Husain, M. K. (11)
Keil, L. C. (28)
Robertson, G. L. (9)
Ross, M. G. (29)
Samson, W. K. (16)
Skowsky, W. R. (14)
Lower detection
limit
0.5 ng/l
0.5 pg/tube*
0.4 ng/l
0.2 pg/tube*
1.2 ng/l
0.3 ng/l
0.1 ng/l
1.6 ng/l
0.5 ng/l
0.8 ng/l
1.0 pg/tube*
0.7 ng/l
ED50
1.2 pg/tube*
8.5 pg/tube*
4.6 ng/l
5.0 pg/tube*
8.3 ng/l
3.5 ng/l
0.8 ng/l
4.2 pg/tube*
1.1 pg/tube*
4.0 ng/l
25.0 pg/tube*
10.8 ng/l
Mean
recovery
102%
72%
80%
103%
96%
88%
68%
64%
96%
70%
80%
84%
Incubation
time
120 h
?
32 h
96h
168h
40h
120h
134h
168h
?
96h
120h
HPLC
analysis
+
—
—
—
—
+
—
—
—
—
—
where absolute concentrations could not be derived, data are adopted as specified in the cited publication
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The radioimmunoassay consistently yielded a detec-
tion limit of 0.3 ng/1 after only 2 χ 20 h of incubation.
In other methods, much longer incubation times are
needed to obtain a comparably low detection limit
(tab. 1). The present assay can therefore be considered
as both highly sensitive, and more rapid than other
assays.
Arginine8-vasopressin immunoreactivity determined
in plasma was characterized by reverse-phase high
performance liquid chromatography. Immunoreactive
argmine8-vasopressin was coeluted with synthetic
arginine8-vasopressin as a single peak, confirming the
specificity of the assay.
Isoosmotic arginine8-vasopressin suppression by cen-
tral volume stimulation during water immersion (30,
31) was clearly demonstrated in accordance with the
findings of other groups, supporting the concept of
inhibition of arginine8-vasopressin secretion by acute
atrial distension (32, 33).
Hypoosmolality as an osmotic stimulus of arginine8-
vasopressin suppression (9) was confirmed by a sig-
nificant decrease of plasma arginine8-vasopressin con-
centrations and plasma osmolality after oral water
loading. Both quantities were closely correlated.
In conclusion, this radioimmunoassay for arginine8-
vasopressin can be considered as highly sensitive, ac-
curate and rapid, and it can be easily established in
any suitably equipped laboratory.
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